During the Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference, Dr. Daniela Santiesteban, Director of Research and Business Development at Salarius Pharmaceuticals, will participate in a virtual panel discussion highlighting the future of targeted cancer therapies. The panel takes place Tuesday, January 19, 2021 at 8:35 am ET. More information on the conference and the panel discussion is available at https://www.nobleconference.com/register/investor-guest.